We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for medicine.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

medicine Product List and Ranking from 33 Manufacturers, Suppliers and Companies

Last Updated： Aggregation Period:Oct 08, 2025～Nov 04, 2025
This ranking is based on the number of page views on our site.

medicine Manufacturer, Suppliers and Company Rankings

Last Updated： Aggregation Period:Oct 08, 2025～Nov 04, 2025
This ranking is based on the number of page views on our site.

  1. マーケットリサーチセンター Tokyo//Service Industry
  2. null/null
  3. スペラファーマ Osaka//others
  4. 4 null/null
  5. 5 立山化成 Toyama//Manufacturing and processing contract
Go to Company Ranking

medicine Product ranking

Last Updated： Aggregation Period:Oct 08, 2025～Nov 04, 2025
This ranking is based on the number of page views on our site.

  1. [Research Material] The Global Market for Neglected Tropical Disease (NTD) Treatments マーケットリサーチセンター
  2. Contract development and manufacturing (CDMO) business for mid-sized molecules (oligonucleotides and peptides) active pharmaceutical ingredients.
  3. For various titrations! The titration "indicator" specified in JIS K8001. 関東化学株式会社 バイオケミカル部
  4. Cavity prevention medicine Gurupepr カツマタ 医薬品製造販売部
  5. Tateyama Kasei Co., Ltd. Kyushu Factory 立山化成

medicine Product List

91～105 item / All 593 items

Displayed results
[Research Material] The Global Market for Cysticercosis Treatment

[Research Material] The Global Market for Cysticercosis Treatment

World Market for Nematode Disease Treatment: Praziquantel, Albendazole, Hospitals & Clinics, Others

This research report (Global Cysticercosis Treatment Market) investigates and analyzes the current state and outlook for the global market for cysticercosis treatment over the next five years. It includes information on the overview of the global cysticercosis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the cysticercosis treatment market focus on praziquantel and albendazole, while the segments by application target hospitals and clinics, among others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for cysticercosis treatment. It also includes the market share of major companies in cysticercosis treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Radiotoxicity Therapeutics

[Research Material] Global Market for Radiotoxicity Therapeutics

World Market for Radiotoxicity Therapeutics: Ionizing Radiation, Non-Ionizing Radiation, Hospitals, Research Institutions, Academic Institutions

This research report (Global Radiation Toxicity Therapeutics Market) investigates and analyzes the current status and outlook for the global market of radiation toxicity therapeutics over the next five years. It includes information on the overview of the global radiation toxicity therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include ionizing radiation and non-ionizing radiation, while the segments by application focus on hospitals, laboratories, and academic institutions. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for radiation toxicity therapeutics. It also includes the market share of major companies in radiation toxicity therapeutics, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] World Market for Left Ventricular Dysfunction Drugs

[Research Material] World Market for Left Ventricular Dysfunction Drugs

World Market for Left Ventricular Dysfunction Drugs: BAY-1142524, CAP-1002, Carvedilol CR, CTX-101, Omecamtiv ...

This research report (Global Left Ventricular Dysfunction Drug Market) investigates and analyzes the current state and outlook for the global market for left ventricular dysfunction drugs over the next five years. It includes information on the overview of the global left ventricular dysfunction drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the left ventricular dysfunction drug market include BAY-1142524, CAP-1002, Carvedilol CR, CTX-101, Omecamtiv Mecarbil, and others, while the segments by application include hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for left ventricular dysfunction drugs. It also includes the market share of major companies in the left ventricular dysfunction drug market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Document] Global Market for Ciprofloxacin Hydrochloride

[Research Document] Global Market for Ciprofloxacin Hydrochloride

World Market for Ciprofloxacin Hydrochloride: Injection, Oral, Eye Drops, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

This research report (Global Ciprofloxacin Hydrochloride (CAS 93107-08-5) Market) investigates and analyzes the current state and outlook for the global market of ciprofloxacin hydrochloride over the next five years. It includes information on the overview of the global ciprofloxacin hydrochloride market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include injections, oral forms, and eye drops, while the segments by application focus on hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size of ciprofloxacin hydrochloride. It also includes the market share of major companies in ciprofloxacin hydrochloride, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] World Market for Calcitonin Gene-Related Peptide Type 1 Receptor

[Research Material] World Market for Calcitonin Gene-Related Peptide Type 1 Receptor

World Market for Calcitonin Gene-Related Peptide Type 1 Receptor: AFAP-3, AGN-241689, CGRP, Erenumab, Others, Heart ...

This research report (Global Calcitonin Gene Related Peptide Type 1 Receptor) investigates and analyzes the current status and outlook for the global market of calcitonin gene-related peptide type 1 receptors over the next five years. It includes information on the overview of the global calcitonin gene-related peptide type 1 receptor market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include AFAP-3, AGN-241689, CGRP, Erenumab, and others, while the segments by application focus on cardiovascular, metabolic disorders, dental pain, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size of calcitonin gene-related peptide type 1 receptors. It also includes the market share of major companies in the calcitonin gene-related peptide type 1 receptor market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Global Market for Epstein-Barr Virus (HHV-4) Infection Treatment

Global Market for Epstein-Barr Virus (HHV-4) Infection Treatment

Global Market for Epstein-Barr Virus (HHV-4) Infection Treatment: Apatinib Mesylate, AR-12, Biltarudine T, and Others ...

This research report (Global Epstein-Barr Virus (HHV-4) Infections Treatment Market) investigates and analyzes the current state and future outlook of the global market for Epstein-Barr virus (HHV-4) infection treatment over the next five years. It includes information on the overview of the global Epstein-Barr virus (HHV-4) infection treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments of the Epstein-Barr virus (HHV-4) infection treatment market by type include mesylate apatinib, AR-12, valteriscel-T, and others, while the segments by application include hospitals, clinics, ASCs, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for Epstein-Barr virus (HHV-4) infection treatment. The market share of major companies in the Epstein-Barr virus (HHV-4) infection treatment...

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Global market for the treatment of Globoid Cell Leukodystrophy (GLD)

Global market for the treatment of Globoid Cell Leukodystrophy (GLD)

Global Market for Treatment of Globoid Cell Leukodystrophy (GLD): RND-001, CMB-200, DUOC-01, Others, Hospitals, ...

This research report (Global Globoid Cell Leukodystrophy Treatment Market) investigates and analyzes the current state and future outlook of the global market for globoid cell leukodystrophy (GLD) treatment over the next five years. It includes information on the overview of the global globoid cell leukodystrophy (GLD) treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for globoid cell leukodystrophy (GLD) treatment by type include RND-001, CMB-200, DUOC-01, and others, while the segments by application focus on hospitals, clinics, and research centers. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for globoid cell leukodystrophy (GLD) treatment. It also includes the market share of major companies in the globoid cell leukodystrophy (GLD) treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Protamine Sulfate Injection

[Research Material] Global Market for Protamine Sulfate Injection

World Market for Protamine Sulfate Injection: 10mg/mL SD Vial 5mL, 10mg/mL SD Vial 25mL, Cardiac Surgery, Childbirth

This research report (Global Protamine Sulfate Injection Market) investigates and analyzes the current status and outlook for the global market of protamine sulfate injection over the next five years. It includes information on the overview of the global protamine sulfate injection market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include 10mg/mL SD vials of 5mL and 10mg/mL SD vials of 25mL, while the segments by application focus on cardiac surgery and childbirth. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for protamine sulfate injection. It also includes the market share of major companies in the protamine sulfate injection market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Acetylsalicylic Acid

[Research Material] The Global Market for Acetylsalicylic Acid

World Market for Acetylsalicylic Acid: Acetylsalicylic Acid Tablets, Acetylsalicylic Acid Capsules, Others, Antipyretic Analgesics, Rheumatoid Arthritis, Others

This research report (Global Acetylsalicylic Acid Market) investigates and analyzes the current status and outlook for the global acetylsalicylic acid market over the next five years. It includes information on the overview of the global acetylsalicylic acid market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments of the acetylsalicylic acid market by type include acetylsalicylic acid tablets, acetylsalicylic acid capsules, and others, while the segments by application focus on antipyretic analgesics, rheumatoid arthritis, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size of acetylsalicylic acid. The report also includes the market share of major companies in acetylsalicylic acid, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Lip Herpes Treatment

[Research Material] The Global Market for Lip Herpes Treatment

Global Market for Lip Herpes Treatment: Acyclovir, Valacyclovir, Famciclovir, Penciclovir, Docosanol, Topical, Oral

This research report (Global Herpes Labialis Treatment Market) investigates and analyzes the current state and outlook for the global market for lip herpes treatment over the next five years. It includes information on the overview of the global lip herpes treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the lip herpes treatment market include acyclovir, valacyclovir, famciclovir, penciclovir, and docosanol, while the segments by application focus on topical and oral treatments. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for lip herpes treatment. It also includes the market share of major companies in lip herpes treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Gene Therapy for Hereditary Genetic Diseases

[Research Material] Global Market for Gene Therapy for Hereditary Genetic Diseases

Global Market for Gene Therapy for Hereditary Genetic Diseases: Eye Diseases, Hematological Disorders, Central Nervous System Disorders, Muscle Disorders, Others, Hospitals, Clinics, Research Institutes, Others

This research report (Global Gene Therapy for Inherited Genetic Disorders) investigates and analyzes the current state and future outlook of the global market for gene therapy for inherited genetic disorders over the next five years. It includes information on the overview of the global gene therapy market for inherited genetic disorders, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for gene therapy for inherited genetic disorders by type include ocular diseases, hematological disorders, central nervous system disorders, muscular disorders, and others, while the segments by application focus on hospitals, clinics, laboratories, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for gene therapy for inherited genetic disorders. It also includes the market share of major companies in gene therapy for inherited genetic disorders, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Ovarian Cancer Gene Therapy

[Research Material] Global Market for Ovarian Cancer Gene Therapy

Global Market for Ovarian Cancer Gene Therapy: Intravenous, Intratumoral, Intraperitoneal, Ovarian Cancer (Details Unknown), Recurrent Ovarian Epithelial Cancer, Platinum-Resistant Ovarian Cancer

This research report (Global Gene Therapy for Ovarian Cancer Market) investigates and analyzes the current status and outlook for the global market of ovarian cancer gene therapy over the next five years. It includes information on the overview of the global ovarian cancer gene therapy market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments of the ovarian cancer gene therapy market by type include intravenous, intratumoral, and intraperitoneal, while the segments by application focus on ovarian cancer (details unknown), recurrent ovarian epithelial cancer, and platinum-resistant ovarian cancer. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for ovarian cancer gene therapy. It also includes the market share of major companies in ovarian cancer gene therapy, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Chemotherapy-Induced Nausea and Vomiting Treatment Drugs

[Research Material] Global Market for Chemotherapy-Induced Nausea and Vomiting Treatment Drugs

World Market for Chemotherapy-Induced Nausea and Vomiting Treatment Drugs: Existing Medications, Akynzeo (Netupitant-Palonosetron FDC), Aloxi (Palonosetron) ...

This research report (Global Chemotherapy-Induced Nausea and Vomiting Drugs Market) investigates and analyzes the current status and outlook for the global market of chemotherapy-induced nausea and vomiting treatment drugs over the next five years. It includes information on the overview of the global chemotherapy-induced nausea and vomiting treatment drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis, among other details. The market segments by type include existing drugs, Akynzeo (netupitant-palonosetron FDC), Aloxi (palonosetron), Emend (aprepitant), Kytril generic (granisetron), Zofran generic (ondansetron), pipeline drugs, SUSTOL (granisetron injection extended-release formulation), and rolapitant. The segments by application focus on serotonin receptor antagonists and NK1 receptor antagonists. The regional segments include North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, and the Middle East.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Hepatic Encephalopathy Treatment Drugs

[Research Material] Global Market for Hepatic Encephalopathy Treatment Drugs

World Market for Hepatic Encephalopathy Treatment Drugs: Injection, Oral, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

This research report (Global Hepatic Encephalopathy Drugs Market) investigates and analyzes the current status and outlook for the global market of hepatic encephalopathy treatment drugs over the next five years. It includes information on the overview of the global hepatic encephalopathy treatment drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on injections and oral medications, while the segments by application target hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of hepatic encephalopathy treatment drugs. It also includes the market share of major companies in the hepatic encephalopathy treatment drugs sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Hypertrophic Cardiomyopathy (HCM) Treatment Drugs

[Research Material] Global Market for Hypertrophic Cardiomyopathy (HCM) Treatment Drugs

Global Market for Hypertrophic Cardiomyopathy (HCM) Treatments: Beta-Adrenergic Blockers, Calcium Channel Blockers, Antiarrhythmic Drugs, Anticoagulants, Hospital Medications ...

This research report (Global Hypertrophic Cardiomyopathy (HCM) Therapeutics) investigates and analyzes the current status and outlook for the global market of hypertrophic cardiomyopathy (HCM) therapeutics over the next five years. It includes information on the global hypertrophic cardiomyopathy (HCM) therapeutics market overview, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include beta-blockers, calcium channel blockers, antiarrhythmics, and anticoagulants, while the segments by application focus on hospital pharmacies, retail pharmacies, and drugstores. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for hypertrophic cardiomyopathy (HCM) therapeutics. The report also includes the market share of major companies in the hypertrophic cardiomyopathy (HCM) therapeutics market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to medicine

COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.